HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase.

Abstract
Recent studies have suggested that 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) increases macrophage phagocytosis through adenosine monophosphate-activated protein kinase (AMPK). However, little information is available on the effects of AICAR on the clearance of apoptotic cells by macrophages, known as efferocytosis, which is essential in maintaining tissue homeostasis and resolving inflammation. AICAR increased p38 MAPK activation and the phagocytosis of apoptotic cells by macrophages, which were inhibited by the p38 MAPK inhibitor, SB203580, the TGF-beta-activated kinase 1 (TAK1) inhibitor, (5Z)-7-oxozeaenol, and siRNA-mediated knock-down of p38α. AICAR increased phosphorylation of Akt, but the inhibition of PI3K/Akt activity using LY294002 did not affect the AICAR-induced changes in efferocytosis in macrophages. CGS15943, a non-selective adenosine receptor antagonist, did not affect AICAR-induced changes in efferocytosis, but dipyridamole, an adenosine transporter inhibitor, diminished the AICAR-mediated increases in efferocytosis. AICAR-induced p38 MAPK phosphorylation was not inhibited by the AMPK inhibitor, compound C, or siRNA-mediated knock-down of AMPKα1. Inhibition of AMPK using compound C or 5'-iodotubercidin did not completely block AICAR-mediated increases in efferocytosis. Furthermore, AICAR also increased the removal of apoptotic neutrophils or thymocytes in mouse lungs. These results reveal a novel mechanism by which AICAR increases macrophage-mediated phagocytosis of apoptotic cells and suggest that AICAR may be used to treat efferocytosis-related inflammatory conditions.
AuthorsHui Quan, Joung-Min Kim, Hyun-Jung Lee, Seong-Heon Lee, Jeong-Il Choi, Hong-Beom Bae
JournalPloS one (PLoS One) Vol. 10 Issue 5 Pg. e0127885 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26020972 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Imidazoles
  • Pyridines
  • Ribonucleotides
  • Aminoimidazole Carboxamide
  • AMPK alpha1 subunit, mouse
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinases
  • MAP kinase kinase kinase 7
  • AMP-Activated Protein Kinases
  • AICA ribonucleotide
  • SB 203580
Topics
  • AMP-Activated Protein Kinases (antagonists & inhibitors, genetics, metabolism)
  • Aminoimidazole Carboxamide (analogs & derivatives, pharmacology)
  • Animals
  • Apoptosis (drug effects, genetics)
  • Enzyme Activation (drug effects, genetics)
  • Gene Knockdown Techniques
  • Imidazoles (pharmacology)
  • MAP Kinase Kinase Kinases (antagonists & inhibitors, genetics, metabolism)
  • Macrophages, Peritoneal (enzymology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Phagocytosis (drug effects, genetics)
  • Phosphorylation (drug effects, genetics)
  • Pyridines (pharmacology)
  • Ribonucleotides (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: